Long-acting injection superior to daily oral HIV PrEP in cisgender women

125423

Sumary of Long-acting injection superior to daily oral HIV PrEP in cisgender women:

  • A long-acting injection of cabotegravir given every 8 weeks was 89% more effective than oral emtricitabine/tenofovir disoproxil fumarate in preventing HIV among cisgender women, according to data released by ViiV Healthcare..
  • According to ViiV, an independent data safety monitoring board recommended the early unblinding of results from the HIV Prevention Trials Network (HPTN) 084 study after an interim analysis showed the long-acting injection was superior to daily emtricitabine/tenofovir disoproxil fumarate (FTC/TDF)….

Want to know more click here go to health news source.

From -

Close

Languages